stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Protalix BioTherapeutics Inc.PLX
$3.060.33%0.01

Protalix BioTherapeutics Inc. (PLX)

Protalix BioTherapeutics Inc. Azioni (PLX) Dati Finanziari

*Tutti i numeri sono espressi in milioni
Data di fine periodo2026-09-302026-06-302026-03-312025-12-312025-09-30
Durata del periodo3 mesi3 mesi3 mesi3 mesi3 mesi
Revenues
10.20%21.93
19.9033.759.1217.85
Cost Of Revenue
1.47%7.88
7.764.134.628.32
1.03%3.08
3.113.053.53-
Selling, General, and Administrative
1.03%3.08
3.113.053.53-
Research and Development
59.11%6.92
4.355.435.64-
Operating Income/Loss
13.38%4.05
4.6721.15-4.662.13
Nonoperating Income/Loss
205.85%0.58
0.19-0.01-0.120.11
Income/Loss From Continuing Operations Before Tax
4.90%4.62
4.8621.14-4.782.24
Income Tax Expense/Benefit, Current
41.70%0.59
1.012.750.57-0.18
Income Tax Expense/Benefit, Deferred
0.07
0.070.070.160.06
Income Tax Expense/Benefit
38.97%0.66
1.082.820.73-0.12
4.87%3.96
3.7818.32-5.502.36
Attributable To Parent
4.87%3.96
3.7818.32-5.502.36
Available To Common Stockholders, Basic
4.87%3.96
3.78--2.36
Basic Average Shares
0.59%80.46
79.9979.85-79.28
Diluted Average Shares
1.24%83.59
82.5683.05-80.81
Basic Earnings Per Share
0.05
0.050.23-0.03
Diluted Earnings Per Share
0.05
0.050.22-0.03

Simile a PLX